Steneker Marloes, Lomax Antony, Schneider Uwe
Department of Radiation Medicine, Paul Scherrer Institute, Villigen, Switzerland.
Radiother Oncol. 2006 Aug;80(2):263-7. doi: 10.1016/j.radonc.2006.07.025. Epub 2006 Aug 17.
A comparative treatment planning study has been performed between intensity modulated photon and proton therapy to investigate the ability of both modalities to spare organs at risk in the head and neck region while keeping target dose homogeneous. Additional advantage of reducing the spot size for IMPT was also investigated. The treatment planning comparison was extended by varying the number of fields to study its effect on the performance of each modality. Risks of secondary cancer induction were also calculated for all modalities.
Five planning CTs were selected for the study. Four different constraints were set to the organs at risk in order to measure the resulting dose homogeneity in the target volume. Five and nine field plans were made for IMXT and 3, 5 and 9 field plans were made for IMPT, for both spot sizes. Dose homogeneity as a function of the mean parotid dose was visualized using a 'pseudo' Pareto-optimal front approach. Risks of secondary cancer were estimated using the organ equivalent dose model.
Critical organs were best spared using 3-field IMPT and, at least for IMPT, little advantage was seen with increasing field numbers. Reducing the spot size does give an advantage. In contrast, there was a significant advantage in going from 5 to 9 fields for IMXT. Secondary cancer risk was lowest for the IMPT plans with reduced spot size, for which normal tissue received the lowest integral dose. Interestingly, although integral dose remained the same, increasing the number of IMPT fields increased the secondary cancer risk, due to the increased volume of tissue irradiated to low dose.
IMPT has a better ability to spare organs at risk than IMXT for the same dose homogeneity. It also significantly reduced the estimated risk of secondary cancer induction and the use of small numbers of fields further increased this advantage. Given that target homogeneity and normal tissue sparing were equally good with the 3 field IMPT, there appears to be a clear rationale to deliver small numbers of fields for IMPT.
开展了一项调强光子治疗与质子治疗的对比治疗计划研究,以调查这两种治疗方式在保持靶区剂量均匀的同时保护头颈部危险器官的能力。还研究了减小调强质子治疗(IMPT)光斑尺寸的额外优势。通过改变射野数量来扩展治疗计划比较,以研究其对每种治疗方式性能的影响。还计算了所有治疗方式诱发二次癌症的风险。
选择5例计划CT用于该研究。对危险器官设置了4种不同的限制条件,以测量靶区内由此产生的剂量均匀性。针对两种光斑尺寸,分别为调强X线治疗(IMXT)制定了5野和9野计划,为IMPT制定了3野、5野和9野计划。使用“伪”帕累托最优前沿方法直观显示作为腮腺平均剂量函数的剂量均匀性。使用器官等效剂量模型估计二次癌症风险。
使用3野IMPT时,关键器官得到了最佳保护,并且至少对于IMPT来说,增加射野数量未见明显优势。减小光斑尺寸确实具有优势。相比之下,从5野增加到9野时,IMXT有显著优势。光斑尺寸减小的IMPT计划的二次癌症风险最低,其正常组织接受的积分剂量最低。有趣的是,尽管积分剂量保持不变,但增加IMPT射野数量会增加二次癌症风险,这是由于接受低剂量照射的组织体积增加所致。
在相同的剂量均匀性条件下,IMPT比IMXT具有更好的保护危险器官的能力。它还显著降低了估计的二次癌症诱发风险,使用少量射野进一步增强了这一优势。鉴于3野IMPT在靶区均匀性和正常组织保护方面同样良好,似乎有明确的理由采用少量射野进行IMPT治疗。